(2024)
Risk of Cardiovascular Disease according to Baseline Low-Density Lipoprotein Cholesterol Level in Different Age Groups in Korean Diabetes Population: A Cohort Study.
DIABETES & METABOLISM JOURNAL.
48,
2
(2024)
Association between underweight and risk of heart failure in diabetes patients.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE.
1,
1
(2023)
Coronary Artery Calcium Score as a Sensitive Indicator of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus: A Long-Term Cohort Study.
ENDOCRINOLOGY AND METABOLISM.
38,
5
(2023)
Impact of mental disorders on the risk of heart failure among Korean patients with diabetes: a cohort study.
Cardiovascular diabetology.
22,
1
(2023)
Association between antidiabetic drugs and the incidence of atrial fibrillation in patients with type 2 diabetes: A nationwide cohort study in South Korea.
DIABETES RESEARCH AND CLINICAL PRACTICE.
198,
(2023)
Body mass index, waist circumference and cardiovascular diseases in transitional ages (40 and 66 years).
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE.
14,
1
(2023)
Association between Low-Density Lipoprotein Cholesterol Level and Cardiovascular Outcomes in Korean Adults: A Nationwide Cohort Study.
DIABETES & METABOLISM JOURNAL.
47,
1
(2023)
Big Data Research in the Field of Endocrine Diseases Using the Korean National Health Information Database.
ENDOCRINOLOGY AND METABOLISM.
38,
1
(2023)
Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus.
DIABETES & METABOLISM JOURNAL.
47,
1
(2022)
Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study.
DIABETES & METABOLISM JOURNAL.
46,
5
(2022)
Effects of Patient-Driven Lifestyle Modification Using Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: Results From the Randomized Open-label PDF Study.
DIABETES CARE.
45,
10
(2022)
Current status of obesity treatment in Korea: based on the 2020 Korean Society for the Study of Obesity guidelines for obesity management.
Journal of the Korean Medical Association.
65,
7
(2022)
Increased Risk of NAFLD in Adults with Glomerular Hyperfiltration: An 8-Year Cohort Study Based on 147,162 Koreans.
JOURNAL OF PERSONALIZED MEDICINE.
12,
7
(2022)
Extra-Glycemic Effects of Anti-Diabetic Medications: Two Birds with One Stone?.
ENDOCRINOLOGY AND METABOLISM.
37,
3
(2022)
A Report of Journal of Obesity and Metabolic Syndrome in the Last 3 Years of Upheaval.
Journal of Obesity and Metabolic Syndrome.
31,
1
(2022)
Changes in Patterns of Physical Activity and Risk of Heart Failure in Newly Diagnosed Diabetes Mellitus Patients.
DIABETES & METABOLISM JOURNAL.
46,
2
(2022)
Dulaglutide Ameliorates Palmitic Acid-Induced Hepatic Steatosis by Activating FAM3A Signaling Pathway.
ENDOCRINOLOGY AND METABOLISM.
37,
1
(2022)
The Influence of Obesity and Metabolic Health on Vascular Health.
ENDOCRINOLOGY AND METABOLISM.
37,
1
(2021)
Changes in Insulin Resistance Index and the Risk of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease without Diabetes: Kangbuk Samsung Health Study.
ENDOCRINOLOGY AND METABOLISM.
36,
5
(2021)
The Effects of Glucose Lowering Agents on the Secondary Prevention of Coronary Artery Disease in Patients with Type 2 Diabetes.
ENDOCRINOLOGY AND METABOLISM.
36,
5
단행본
(2020)
지방간학.
범문출판사.
공동
(2020)
내분비기능검사의 수행과 판독.
군자출판사.
공동
(2020)
임상의사를 위한 노화학.
군자출판사.
공동
(2018)
2018 이상지질혈증 치료지침 제4판.
도서출판 아카데미아.
주저자
(2010)
당뇨병 희망 프로젝트.
동아일보사.
공동
(2009)
임신성 당뇨병 쉽게 알기.
한진기획인쇄.
공동
(2007)
당뇨병 진료지침.
엠엠케이커뮤니케이션즈.
공동
(2007)
당뇨병 쉽게 알기.
한진기획인쇄.
공동
학술회의논문
(2020)
How to start clinical research and write a good paper.
Asia-Oceania Congress on Endocrinology-Seoul International Congress on Endocrinology and Metabolism.
대한민국
(2020)
SGLT1/2 dual inhibitor.
Asia-Oceania Congree on Endocrinology-Seoul International Congress on Endocrinology and Metabolism.
대한민국
(2020)
Global Perspectives on Building Collaboration through publishing.
Asia-Oceania Congress on Endocrinology-Seoul International Congress on Endocrinology and Metabolism.
대한민국
(2020)
Clinical implications of vascular calcification in patients with diabetes.
21th International Vascular Biology Meeting.
대한민국
(2020)
Non-alcoholic fatty liver disease as cardiovascular risk factors.
International Congress on Obesity and Metabolic Syndrome.
대한민국
(2020)
The effect of obesity on diabetes in 44 years vs. 66 years.
International Congress on Obesity and Metabolic Syndrome.
대한민국
(2020)
Dyslipidemia guidelines.
The 16th KSIC International Conference in Winter.
대한민국
(2019)
EnM 학술지의 발전 경험과 AGMR을 위한 시사점.
대한노인병학회 추계학술대회.
대한민국
(2019)
이상지질혈증 치료의 최신가이드라인과 노하우.
추계 내분비학회 개원의 연수강좌.
대한민국
(2019)
ESC/EAS Guideline.
대한심장학회 추계학술대회.
대한민국
(2019)
How to establish the hospital-based data for research.
International Congress of Diabetes and Metabolism.
대한민국
(2019)
Guideline updates in diabetes: dyslipidemia.
International Congress of Diabetes and Metabolism.
대한민국
(2019)
Protective mechanism of SGLT2 inhibitor on heart failure.
International Congress of Diabetes and Metabolism.
대한민국
(2019)
The implication of Lipoprotein(a) in metabolic diseases.
International Congress on Lipid & Atherosclerosis.
대한민국
(2019)
Weight cycling: consequences and prevention of weigth regain.
International Congress on Obesity and MEtabolic Syndrome.
대한민국
(2019)
Systems to provide medicalnutritional therapy for diabetes inKorea.
The 62nd Annual Meeting of the Japan Diabetes Society.
일본
(2019)
인슐린을 거부하는 당뇨병 환자에서의 경구약물치료, 단독부터 4제병용까지.
대한의원협회 춘계집중심화 연수강좌 및 초음파 연수교육.
대한민국
(2019)
Isolation and production of primary vascular smooth muscle cell.
춘계당뇨병학회.
대한민국
(2018)
국가검진데이터 및 종합검진데이터를 이용한 논문작성법.
제26차 당뇨병 연구 동계워크샵.
대한민국
(2018)
SGLT2 inhibitors: SGLT2 inhibition or SGLT1-SGLT2 dual inhibition, which will be better?.
국제심혈관약물치료학회 한국지회.
대한민국
